Salveen Richter
Stock Analyst at Goldman Sachs
(4.58)
# 955
Out of 4,609 analysts
529
Total ratings
50.5%
Success rate
12.1%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics | Rated: Buy | $67 → $80 | $59.70 | +34.00% | 7 | Aug 5, 2026 | |
| RAPP Rapport Therapeutics | Maintained: Buy | $58 → $62 | $42.44 | +46.09% | 4 | Aug 5, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Buy | $652 → $653 | $484.83 | +34.69% | 29 | Aug 4, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $130 | $131.76 | -1.34% | 16 | Aug 3, 2026 | |
| AMRX Amneal Pharmaceuticals | Rated: Buy | $21 | $18.46 | +13.76% | 1 | Jul 31, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $965 → $972 | $768.58 | +26.47% | 25 | Jul 30, 2026 | |
| INCY Incyte | Maintained: Hold | $110 → $118 | $119.80 | -1.50% | 27 | Jul 29, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Hold | $66 → $69 | $54.19 | +27.33% | 17 | Jul 29, 2026 | |
| QURE uniQure | Maintained: Hold | $46 | $44.24 | +3.98% | 23 | Jul 29, 2026 | |
| SMMT Summit Therapeutics | Maintained: Buy | $41 | $13.53 | +203.03% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $31.72 | +0.88% | 17 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $49 → $67 | $56.26 | +19.10% | 47 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $27 | $24.93 | +8.30% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $31 | $19.69 | +57.44% | 12 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $13 | $6.46 | +101.24% | 6 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $10.28 | +221.01% | 13 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $206.63 | +20.99% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $550 | $228.72 | +140.47% | 22 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 | $10.97 | -17.96% | 17 | Jun 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 | $134.23 | -33.70% | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $425 → $389 | $407.83 | -4.62% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $25.11 | +63.28% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $25.52 | +37.15% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $7 | $5.37 | +30.35% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $127 → $69 | $59.91 | +15.17% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $17.65 | -9.35% | 2 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $26 | $14.49 | +79.43% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $15.93 | +6.72% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $27.70 | -42.24% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $17 | $28.80 | n/a | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.81 | n/a | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $48 | $52.45 | n/a | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $40 | $24.42 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.54 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $3.50 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $30 | $19.92 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $5 | $24.60 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $81.99 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $63.63 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $57.75 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $2.75 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $31 | $1.95 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $240.03 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.08 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $13.45 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $7.47 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $9 | $3.17 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $6 | $3.51 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.61 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $126 → $131 | $514.12 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $2.79 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $5.44 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $47 | $86.91 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $2 | $8.73 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $519.01 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $2.79 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.000001 | n/a | 1 | Dec 2, 2011 |
Enliven Therapeutics
Aug 5, 2026
Rated: Buy
Price Target: $67 → $80
Current: $59.70
Upside: +34.00%
Rapport Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $58 → $62
Current: $42.44
Upside: +46.09%
Vertex Pharmaceuticals
Aug 4, 2026
Rated: Buy
Price Target: $652 → $653
Current: $484.83
Upside: +34.69%
Gilead Sciences
Aug 3, 2026
Maintained: Hold
Price Target: $130
Current: $131.76
Upside: -1.34%
Amneal Pharmaceuticals
Jul 31, 2026
Rated: Buy
Price Target: $21
Current: $18.46
Upside: +13.76%
Regeneron Pharmaceuticals
Jul 30, 2026
Maintained: Buy
Price Target: $965 → $972
Current: $768.58
Upside: +26.47%
Incyte
Jul 29, 2026
Maintained: Hold
Price Target: $110 → $118
Current: $119.80
Upside: -1.50%
Ionis Pharmaceuticals
Jul 29, 2026
Maintained: Hold
Price Target: $66 → $69
Current: $54.19
Upside: +27.33%
uniQure
Jul 29, 2026
Maintained: Hold
Price Target: $46
Current: $44.24
Upside: +3.98%
Summit Therapeutics
Jul 28, 2026
Maintained: Buy
Price Target: $41
Current: $13.53
Upside: +203.03%
Jul 21, 2026
Maintained: Hold
Price Target: $32
Current: $31.72
Upside: +0.88%
Jul 21, 2026
Rated: Hold
Price Target: $49 → $67
Current: $56.26
Upside: +19.10%
Jul 20, 2026
Maintained: Hold
Price Target: $25 → $27
Current: $24.93
Upside: +8.30%
Jul 20, 2026
Maintained: Buy
Price Target: $22 → $31
Current: $19.69
Upside: +57.44%
Jul 20, 2026
Maintained: Buy
Price Target: $11 → $13
Current: $6.46
Upside: +101.24%
Jul 20, 2026
Maintained: Buy
Price Target: $33
Current: $10.28
Upside: +221.01%
Jul 13, 2026
Maintained: Buy
Price Target: $250
Current: $206.63
Upside: +20.99%
Jun 25, 2026
Maintained: Buy
Price Target: $550
Current: $228.72
Upside: +140.47%
Jun 14, 2026
Maintained: Sell
Price Target: $9
Current: $10.97
Upside: -17.96%
Jun 10, 2026
Maintained: Hold
Price Target: $89
Current: $134.23
Upside: -33.70%
Jun 5, 2026
Maintained: Buy
Price Target: $425 → $389
Current: $407.83
Upside: -4.62%
Jun 1, 2026
Maintained: Buy
Price Target: $41
Current: $25.11
Upside: +63.28%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $25.52
Upside: +37.15%
May 12, 2026
Initiated Coverage: Hold
Price Target: $7
Current: $5.37
Upside: +30.35%
May 11, 2026
Initiated Coverage: Hold
Price Target: $127 → $69
Current: $59.91
Upside: +15.17%
May 4, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $17.65
Upside: -9.35%
Apr 9, 2026
Maintained: Buy
Price Target: $14 → $26
Current: $14.49
Upside: +79.43%
Feb 25, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $15.93
Upside: +6.72%
Oct 30, 2025
Maintained: Hold
Price Target: $16
Current: $27.70
Upside: -42.24%
Aug 7, 2025
Maintained: Sell
Price Target: $15 → $17
Current: $28.80
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $19
Current: $10.81
Upside: n/a
Aug 5, 2025
Maintained: Hold
Price Target: $47 → $48
Current: $52.45
Upside: n/a
Jan 28, 2025
Maintained: Buy
Price Target: $46 → $40
Current: $24.42
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $8.54
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $3.50
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $37 → $30
Current: $19.92
Upside: n/a
Feb 16, 2024
Maintained: Hold
Price Target: $48 → $5
Current: $24.60
Upside: n/a
Jan 8, 2024
Maintained: Buy
Price Target: n/a
Current: $81.99
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $63.63
Upside: n/a
Jul 31, 2023
Maintained: Buy
Price Target: $53
Current: $57.75
Upside: n/a
Jun 12, 2023
Maintained: Sell
Price Target: $7
Current: $2.75
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $32 → $31
Current: $1.95
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $225
Current: $240.03
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.08
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $13.45
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $2 → $1
Current: $7.47
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $8 → $9
Current: $3.17
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $34 → $6
Current: $3.51
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.61
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $126 → $131
Current: $514.12
Upside: n/a
Nov 9, 2020
Maintained: Sell
Price Target: $11
Current: $2.79
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $5.44
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $45 → $47
Current: $86.91
Upside: n/a
Nov 13, 2019
Maintained: Sell
Price Target: $4 → $2
Current: $8.73
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $519.01
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $2.79
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.000001
Upside: n/a